Cronos Group Stock Price to Suffer an Earnings Restatement Penalty

Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…

Read More

Psychedelic Medicine Stocks are on the Rise

As cannabis legalization slowly continues to make its way through the United States and the rest of the world, cannabis stocks have continued to grow in demand. However, a surge in new cannabis companies looking to capitalize on the new “green rush” led to far too much saturation within the industry. This has led to an industry-wide slowdown, as the…

Read More

1 Cannabis Stock I’m Buying While It’s Still Cheap

You’ll think I’m crazy, but with markets at lows not seen in years, perhaps the craziness of the market place is getting to me. I’ve been looking hard for cheap stocks to buy up while I can. Whereas before I would have to have a couple thousand dollars stashed away, right now I might need only a couple hundred bucks…

Read More

Why the Cronos Group Stock Price Fell 18.3% in February

The Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) stock price fell 18.3% in February. The market continues to fall and company-specific uncertainty remains high. This is making any prediction for the Cronos Group stock price very uncertain and precarious. Fears of the potential severity of the coronavirus have ruled the market since February. This certainly continues today. As I write this article, I…

Read More

Why the Canopy Growth (WEED) Stock Price Fell 15.5% in February

Marijuana stocks certainly have enough problems these days without adding coronavirus fears to the mix. Canopy Growth (TSX:WEED)(NYSE:CGC) is down almost 40% since January 2019. While it remains a leader in the cannabis industry, times are tough. Canopy Growth has felt the sting of a troubled legalization process in Canada and an oversupply of cannabis. Add to this a general…

Read More

Canopy Growth’s (TSX:WEED) CEO Cracks the Whip: Will the Stock Price Jump?

Canadian marijuana giant Canopy Growth (TSX:WEED)(NYSE:CGC) made the big announcement that it’s shutting down two very large greenhouses and laying off about 500 employees as it undergoes an organizational and strategic review that could positively impact the company’s stock price in the long term. Newly installed CEO David Klein is a strong numbers man. It was only a matter of…

Read More

Is This the Perfect Time to Buy Canopy Growth (TSX:WEED) Stock?

Investing isn’t just about being right; it’s also about being right at the perfect time. In the early 90s you could have predicted that the rising crop of internet startups were likely to create trillions of dollars in value over their lifetime. However, if you’d invested in these companies right away, you would have probably lost all your money in…

Read More

Should You Consider Aurora Cannabis (TSX:ACB) Stock at These Levels?

Though the leading pot stock Aurora Cannabis (TSX:ACB)(NYSE:ACB) showed some recovery recently, uncertainty might continue to weigh in. Its immense volatility might have worked in favour of the traders, but long-term investors have been brutally burned. The stock has lost more than 75% in the last 12 months. Aurora Cannabis’s poor Q2 show Aurora Cannabis yet again reported a loss…

Read More

Canopy Growth’s (TSX:WEED) Latest 62% Revenue Growth Isn’t Repeatable

Canopy Growth (TSX:WEED)(NYSE:CGC) stock soared over 15% on Friday after the cannabis firm released a strong earnings report that revealed a 62% sequential net revenue growth to $124 million for its fiscal Q3 2019 ended in December 2019. Such high double-digit growth rates, especially on a sequential quarter-over-quarter basis, deserve a huge celebration and should naturally drive the stock price…

Read More